ISRG peers and competitors
Intuitive Surgical, Inc. · end-of-day data as of Oct 16, 2026
Intuitive Surgical, Inc.
$426.70+26.4%
Buy · 34 analystsPT $478.50 +12.1%
ISRG’s peers by industry and size include Abbott Laboratories (ABT), Pfizer (PFE) and Danaher (DHR). Among these 12 companies ISRG ranks 4th by market cap ($151B); its P/E of 48.5 compares with a median of 31.4 for its peers.
Peers by industry and size
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 | $104.89 | +0.2% | -17.7% | +16.6% | 33.7 | $181B | ||
| 2 | $29.58 | +0.5% | 0.0% | -7.1% | 39.1 | $169B | ||
| 3 | $229.04 | -1.1% | -4.8% | +2.8% | 40.7 | $161B | ||
| 4 | $426.70 | -0.3% | -28.0% | +12.1% | 48.5 | $151B | ||
| 5 | $499.74 | -1.8% | -10.4% | +14.0% | 29.1 | $127B | ||
| 6 | $59.75 | -1.4% | -11.3% | +9.4% | 13.2 | $122B | ||
| 7 | $191.75 | -1.0% | -1.0% | -6.2% | 57.8 | $52.23B | ||
| 8 | $238.97 | -1.3% | -12.7% | +3.7% | 23.0 | $33.61B | ||
| 9 | $384.02 | +0.3% | 0.0% | +1.9% | 49.1 | $27.03B | ||
| 10 | $85.81 | -2.3% | -7.2% | +3.6% | 10.5 | $14.61B | ||
| 11 | $25.28 | -1.9% | -10.8% | -14.8% | — | $13.07B | ||
| 12 | $57.94 | +0.9% | -31.3% | +0.9% | 19.8 | $11.02B |
Data as of Oct 16, 2026 close.